tabetha7
As a nurse I've seen many different tapers of many different medications but the only experience I have of Eltrombopag is my own. I went from 50mg to alternating 50mg with 25mg then 25mg x2 days followed by 50mg on the third day. However after a virus induced relapse I went back up to 50mg a day then ended up on 75mg a day a couple of years ago.
Joint pains, very poor sleep pattern and iron deficiency anaemia were the worst side effects.
After my 2nd Covid jab (Pfizer) last summer my count dropped to 14 and would not come back up so I stopped Eltrombopag and against my better judgement went back onto Romiplostim (N Plate) . The side effects of that are awful too in my case. It stopped working after my 3rd dose of Pfizer with a count of 6 so I want back onto Eltrombopag started at 25mg just before last Christmas and within a month was back on 75mg. Joint pains are back as is appalling sleep pattern. Taking iron supplements from the day I went back on it.
I've had my 4th Pfizer today. Have bloods booked for next Friday then seeing haematologist on 28th.
Quite frankly I do not care what my count is I will be informing her I will not stay on 75mg/day any longer.
When it gets to the stage that the side effects are worse than the condition being treated then the treatment reduces/stops is my new mantra and I'm sticking to it.
Gone are the days when doctors were 'god'. Over here in the UK our ITP Association has produced a shared care decision tool kit.
I've copied a section for you (see below). I've also sent you a private message which you should be able to access at top right of the grey area
What is shared decision making?
Shared decision making is when clinicians and patients work together in collaboration, putting people at the centre of decisions about their own treatment and care.
Shared decision making also supports people to develop the knowledge, skills, and confidence they need to manage and make informed decisions about their own health and health care.
Why shared decision making matters
For care to be enabling, the relationship between clinicians and patients needs to be a partnership rather than just the health care professional directing.When patients and clinicians make decisions together
Both the clinician and patient understand what is important to the other
Patients feel empowered to make informed choices and their treatment and care plan takes account of their perspective
Health and other care professionals can tailor the care or treatment to the needs of the individual
The importance of shared decision making mechanisms in ITP management and careFor ITP patients:
The care and support you receive should consider your needs and preferences
You have the right to be involved in discussion and make decisions about your treatment and care, together with a healthcare professional
You should feel empowered to clarify issues relating to your treatment and care with health care professionals
Your circumstances may change, so it is important that your treatment plan is continuously reviewed and a joint decision is taken on the future approach